An Ethical Justification for Expanding the Notion of Effectiveness in Vaccine Post-Market Monitoring: Insights from the HPV Vaccine in Canada

Public Health Ethics 9 (1):78-91 (2016)
  Copy   BIBTEX

Abstract

Health regulators must carefully monitor the real-world safety and effectiveness of marketed vaccines through post-market monitoring in order to protect the public’s health and promote those vaccines that best achieve public health goals. Yet, despite the fact that vaccines used in collective immunization programmes should be assessed in the context of a public health response, post-market effectiveness monitoring is often limited to assessing immunogenicity or limited programmatic features, rather than assessing effectiveness across populations. We argue that post-market monitoring ought to be expanded in two ways to reflect a ‘public health notion of post-market effectiveness’, which incorporates normative public health considerations: effectiveness monitoring should yield higher quality data and grant special attention to underrepresented and vulnerable populations; and the scope of effectiveness should be expanded to include a consideration of the various social factors that maximize a vaccine’s effectiveness at the population level, paying particular attention to how immunization programmes impact related health gradients. We use the case of the human papillomavirus vaccine in Canada to elucidate how expanding post-market effectiveness monitoring is necessary to close the gap between clinical practice and public health, and to ensure that vaccines are effective in a morally relevant sense

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,139

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Public health, public trust and lobbying.Matthew K. Wynia - 2007 - American Journal of Bioethics 7 (6):4 – 7.
Is symmetrical communication ethical and effective?Yi-Hui Huang - 2004 - Journal of Business Ethics 53 (4):333-352.
Ethically compromised vaccines in Australia.Kerri Anne Brussen - 2012 - Chisholm Health Ethics Bulletin 17 (3):1.

Analytics

Added to PP
2015-01-30

Downloads
23 (#626,176)

6 months
6 (#349,140)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Maxwell Smith
University of Western Ontario

Citations of this work

No citations found.

Add more citations